NCT06260579

Brief Summary

This multicentre two-phased RCT aims to evaluate implementation potential, cost-effectiveness, effectiveness, and the role of exercise intensity of a home-based exercise and physical activity intervention to improve de novo kidney transplant recipients' physical fitness, cardiovascular health, gut microbiome characteristics, and health-related quality of life. The first phase of this study comprehends a six-month exercise training intervention. Patients will be randomized into (i) a sham intervention consisting of low-intensity balance and stretching exercises (LIT), (ii) a moderate-intensity aerobic and strength training intervention (MIT), or (iii) a moderate- and high-intensity aerobic and strength training intervention (MHIT). The second phase of this study comprehends a physical activity maintenance intervention provided to MIT and MHIT but not LIT. A total of 147 de novo kidney transplant recipients will be recruited from two independent Belgian transplant centres i.e. UZ Leuven and UZ Ghent.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
147

participants targeted

Target at P75+ for not_applicable

Timeline
44mo left

Started Nov 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
Nov 2022Dec 2029

Study Start

First participant enrolled

November 14, 2022

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

January 25, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

February 15, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
4.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2029

Expected
Last Updated

February 15, 2024

Status Verified

February 1, 2024

Enrollment Period

2.9 years

First QC Date

January 25, 2024

Last Update Submit

February 7, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in peak oxygen consumption (VO2peak)

    Assessed by a maximal cardiopulmonary exercise test

    6, 12 and 24 months follow-up

Secondary Outcomes (1)

  • Health-related physical fitness

    3, 6, 9, and 24 months after kidney transplantation

Study Arms (3)

Low intensity training (LIT)

SHAM COMPARATOR

6 months of low-intensity flexibility and balance exercises, not followed by a formal physical activity intervention

Behavioral: Exercise/physical activity

Moderate-intensity training (MIT)

EXPERIMENTAL

6 months of exercise intervention (moderate intensity), followed by a co-developed physical activity intervention

Behavioral: Exercise/physical activity

Moderate- and high-intensity training group (MHIT)

EXPERIMENTAL

6 months of exercise intervention (moderate-intensity followed by high-intensity), followed by a co-developed physical activity intervention

Behavioral: Exercise/physical activity

Interventions

personalized exercise training and physical activity program

Low intensity training (LIT)Moderate- and high-intensity training group (MHIT)Moderate-intensity training (MIT)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • De novo adult KTRs

You may not qualify if:

  • Underlying heart disease, defined as aberrant CPET, unstable angina, non-revascularized lesions or life-threatening arrhythmias
  • Uncontrolled hypertension
  • Uncontrolled diabetes, defined as HbA1c ≥ 9%
  • Musculoskeletal disorders not allowing physical training on a cycle ergometer, or any other medical reasons by the physician considered to be a contraindication for moderate or high-intensity physical exercise
  • Multi-organ transplantation
  • Ongoing treatment for malignancies
  • Unable to understand Dutch
  • No access to smartphone and/or computer with internet access
  • Severe pulmonary disease defined as either forced vital capacity (FVC) \<50%, one-second value (FEV1) \<50%, or a diffusing capacity for carbon monoxide (DLCO) \<40% that excludes all serious underlying respiratory disease (pulmonary fibrosis, COPD GOLD II-IV, PAH).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

UZ Ghent

Ghent, 9000, Belgium

RECRUITING

UZ Leuven

Leuven, 3000, Belgium

RECRUITING

Related Publications (1)

  • De Smet S, Vandecruys M, De Beir J, Leunis S, Wyngaert KV, Renier M, de Loor H, Goetschalckx K, Naesens M, De Smedt D, Verbeke F, Stalmans I, Fieuws S, Glorieux G, Van Eijgen J, Van Criekinge H, Raes J, De Geest S, Van Biesen W, Kuypers D, Nagler E, Calders P, Monbaliu D, Cornelissen V, Van Craenenbroeck AH. Home-based exercise and physical activity intervention after kidney transplantation: impact of exercise intensity (PHOENIX-Kidney). Protocol for a multicentre randomized controlled trial. Clin Kidney J. 2025 Apr 24;18(11):sfaf114. doi: 10.1093/ckj/sfaf114. eCollection 2025 Nov.

MeSH Terms

Conditions

Motor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Amaryllis Van Craenenbroeck, MD, PhD

    KU Leuven

    PRINCIPAL INVESTIGATOR
  • Patrick Calders, PhD

    University Ghent

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Amaryllis Van Craenenbroeck, MD, PhD

CONTACT

Stefan De Smet, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessors are blinded to the group allocation of the patients. Due to the nature of the intervention, blinding of the patients is not possible. However, a sham training intervention is provided to the control group.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Parallel group randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 25, 2024

First Posted

February 15, 2024

Study Start

November 14, 2022

Primary Completion

September 30, 2025

Study Completion (Estimated)

December 1, 2029

Last Updated

February 15, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations